LQDA Liquidia Corp Insider Trading

Sarah Krepp (CHRO) sells 7,864 shares at $71.51 avg for $562,360.74 under pre-arranged 10b5-1 plan

Sarah Krepp, Chief Human Resource Officer at Liquidia Corp, completed two separate sales totaling 7,864 shares for $562,360.74 under a pre-arranged 10b5-1 trading plan adopted on 2023-12-15, meaning this is a scheduled transaction rather than a discretionary decision. She retains 117,178 shares of non-derivative holdings post-transaction while maintaining an additional 31,787 Performance Stock Units as derivative securities. The current stock price of $76.49 is 7.8% below the 52-week high of $82.96, and her recent cross-ticker track record shows prior sells with average 90-day returns of +88.5%, though same-ticker outcomes at LQDA are mixed: her three prior trades here produced +10.9%, +10.9%, and +88.5% over their respective measurement windows.

CFO/COO Kaseta sells 20,430 shares ($1.5M) at LQDA under scheduled 10b5-1 plan; retains 345,805 shares plus 105,465 derivative holdings.

Michael Kaseta, CFO and COO, executed 2 sales totaling 20,430 shares for $1,460,964.71 on 2026-07-13 under a pre-arranged 10b5-1 trading plan adopted 2023-12-15, representing -5.6% of his pre-transaction holdings. The transaction occurred at a blended average price of $71.51, while the current price stands at $76.49. His cross-ticker track record shows 10 prior sells with an average 90-day return of +68.5%, while his prior 5 trades specifically at LQDA (April 2026) posted 90-day returns of +78.0% to +103.1%. The scheduled nature of the sale precludes timing-based interpretation; notably, Liquidia reported latest-quarter revenue of $132,865,000.00 and net income of $52,862,000.00, though the company was unprofitable over its most recent full fiscal year with a P/E of 305.96.

CEO Roger Jeffs sold 35,249 shares at $71.39–$71.52 ($2.5M) via scheduled 10b5-1 plan at LQDA

Roger Jeffs, Chief Executive Officer of Liquidia Corp, executed 2 separate sales totaling 35,249 shares for $2,520,682.83 at blended average price $71.51 on 2026-07-13. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2023-12-15, meaning it was scheduled rather than discretionary. Post-transaction, Jeffs retains 1,130,426 non-derivative shares, and separately maintains 226,330 shares in derivative holdings (Performance Stock Units), indicating continued equity ownership beyond this sale. His prior sales at LQDA over the past month (five trades between 2026-05-19 and 2026-05-26) all showed positive subsequent 30-day returns ranging from +15.5% to +27.4%, tracking the stock's robust +90.6% gain over 90 days and +7.4% over 30 days. The company reported annual revenue growth of +1031.2% year-over-year on latest quarterly revenue of $132,865,000.00 and net income of $52,862,000.00, though it was unprofitable over its most recent full fiscal year. The continued holding of substantial derivative positions alongside non-derivative shares reflects the CEO's ongoing interest in the company's equity performance despite the scheduled divestiture.

General Counsel Russell Schundler sells 14,738 shares (~$1.1M) at $71.39–$71.52 under pre-arranged 10b5-1 plan

Russell Schundler, General Counsel of Liquidia Corp, executed 2 separate sales totaling 14,738 shares for $1,053,925.78, reducing his non-derivative holdings from 620,700 to 605,962 shares. This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2023-12-15, meaning it is scheduled rather than discretionary. Post-transaction, the insider retains 86,639 shares in derivative holdings (Performance Stock Units), so the position is not fully exited. The stock traded at $71.39–$71.52 during the sale window and currently stands at $76.49, reflecting a +7.4% gain over the prior 30 days and +90.6% over 90 days, placing it 7.8% below its 52-week high of $82.96. Liquidia reported extraordinary annual revenue growth of +1031.2% but remains unprofitable on a full-year basis despite the latest quarter showing positive net income, presenting a mixed financial profile typical of rapid-growth biotech companies. The scheduled nature of this sale under a pre-arranged plan insulates this activity from motivation-based interpretation; investors should note the derivative holdings remain substantial relative to the non-derivative stake that was partially reduced.

CMO Rajeev Saggar sells 9,926 shares ($709.8K) at $71.51 avg under 10b5-1 plan; retains 171.8K shares plus 66,046 derivative holdings

Rajeev Saggar, Chief Medical Officer of Liquidia Corp, executed 2 separate sales totaling 9,926 shares for $709,816.13 on 2026-07-13 under a pre-arranged 10b5-1 trading plan adopted on 2023-12-15. His post-transaction non-derivative holdings remain at 171,799 shares, with an additional 66,046 shares held in derivative form (Performance Stock Units). The stock traded at $76.49 at filing time, representing a 52-week position of -7.8% from the $82.96 high. Over the same quarterly period, the stock has advanced +7.4% (30-day) and +90.6% (90-day). Liquidia's fundamentals show a dramatic revenue expansion (+1031.2% annual growth) with $52.9M net income in the latest quarter, though full-year results were negative; the P/E of 305.96 reflects a highly compressed earnings multiple. The scheduled nature of this transaction precludes timing-based analysis, and the insider's substantial derivative stake and retained common holdings indicate material ongoing economic exposure to the company.

Director Stephen M Bloch sold 75,000 shares of LQDA at blended average $80.68 for $6.1M (2026-07-06/07).

Director Stephen M Bloch executed 3 separate sales totaling 75,000 shares for $6,051,170.42 over two trading days, reducing his holdings from 855,073 shares to 780,073 shares (-8.8% of pre-transaction holdings). The sales occurred near the stock's 52-week high of $82.96, with transactions at $80.18, $80.48, and $81.31, compared to a current price of $79.47. Notably, Bloch has already executed 5 prior sells at LQDA within the past three weeks (2026-06-12 through 2026-06-22), establishing a pattern of sustained liquidation. The company's fundamentals present a mixed picture: revenue of $132,865,000 and net income of $52,862,000 in the latest quarter, but full-year net income was negative, with an extreme P/E of 317.88 and annual revenue growth of +1031.2%, suggesting a highly volatile growth story. The rapid succession of director sales warrants attention to whether there are material developments or valuation concerns prompting the liquidation pattern.

Director Stephen M Bloch sold 25,000 shares at $79.47 avg for $1,986,694.76; retains 855,073 shares after -2.8% reduction.

Stephen M Bloch sold 25,000 shares across 2 separate transactions on 2026-07-01 at blended average price $79.47, raising $1,986,694.76. His remaining post-transaction holdings of 855,073 shares represent a -2.8% reduction from pre-transaction levels of 880,073 shares. This sale occurs when the stock trades at $79.21, near its 52-week high of $80.98 (within -2.2% of peak), following a 30-day gain of +28.1% and 90-day gain of +112.0%. His prior 5 trades at LQDA across 2026-06 were all sells, with no measurable 90-day outcomes yet available; his cross-ticker track record shows 20 prior sells with a timing pattern of 0 of 0 well-timed at the 90-day mark. The company's fundamentals show recent quarterly revenue of $132,865,000.00 and net income of $52,862,000.00, but it was unprofitable over its most recent full fiscal year, paired with an extreme P/E of 316.84 and market cap of $7,043,994,721.79.

Director Stephen M Bloch sold 100,000 shares (100.0K shares) of LQDA for $7,573,703.95 on 2026-06-22, reducing stake by 10.2%

Stephen M Bloch, a Director at Liquidia Corp, executed two separate sales totaling 100,000 (100.0K shares) for $7,573,703.95 ($7.6M) on 2026-06-22, leaving him with 880,073 shares (880.1K shares) post-transaction. This sale reduced his holdings by 10.2% and occurred at a blended average price of $75.74, near the current price of $75.54 and within 2.0% of the 52-week high of $77.09. The timing is notable: the stock has appreciated 23.9% over 30 days and 105.4% over 90 days, suggesting the sale occurred after substantial recent gains. Bloch has a track record of 20 prior sells across all tickers, and this represents the fifth distinct trade at LQDA within a 12-day window (2026-06-11 through 2026-06-22), all sales with no yet-measurable outcomes. The company shows strong recent revenue of $132,865,000.00 and net income of $52,862,000.00, but carries a notably elevated P/E of 302.16 and was unprofitable on a full-year basis despite +1031.2% annual revenue growth, suggesting significant valuation and profitability tensions that merit investor scrutiny of the transaction pattern.

Director Bloch sells 196,111 shares at avg $71.45 for $14.0M; holds 980,073 post-sale

Stephen M Bloch, a Director at Liquidia Corp, executed 4 separate sales totaling 196,111 shares for $14,012,579.79 at a blended average price of $71.45 on June 12 and 15, 2026. The sale reduced his holdings from 1,176,184 shares to 980,073 shares, a 16.7% reduction in position size. The transaction occurred near the 52-week high of $73.22 and well above the current price of $68.01, suggesting the shares were sold at elevated valuations relative to recent market levels. The company's fundamentals show strong recent quarterly revenue of $132,865,000.00 and net income of $52,862,000.00, though the P/E of 272.04 and full-year unprofitability raise questions about valuation sustainability; Bloch's sale timing at such elevated levels may warrant investor attention given the significant position reduction and the company's high multiples.

CHRO Krepp sells 24,880 shares at $70.28 under pre-arranged 10b5-1 plan; holds 121,863 shares post-trade

Sarah Krepp, Chief Human Resource Officer, executed 2 separate sales totaling 24,880 shares for $1,748,526.59 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-12. This is a scheduled transaction, not discretionary activity. Her post-transaction holdings of 121,863 shares represent a 17.0% reduction from prior holdings of 146,743 shares. In her prior same-ticker activity at LQDA, a March 2026 sale showed 90-day returns of +88.5%, indicating sales have historically preceded continued stock appreciation rather than declines. The stock is currently at $71.80, near its 52-week high of $72.70 and up 94.8% over 90 days, though the company reported negative full-year net income despite a latest-quarter net income of $52,862,000.00.